All Companies
Ticker AKRO
This stock is no longer actively trading
You reached the page — here's exactly what AKRO is, and why it's out of scope for now.
What this ticker is
AKRO
Akero Therapeutics, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $4.5B
Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing cardio-metabolic disorders, with a specific focus on nonalcoholic steatohepatitis (NASH). Its primary objective is the creation of therapeutic agents aimed at re-establishing metabolic equilibrium and enhancing overall well-being. The company's flagship investigational drug is efru…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted